Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 16.85
-0.45 (-2.60%)
Sep 8, 2026, 1:08 PM CST
Anxo Pharmaceutical Market Cap
Anxo Pharmaceutical has a market cap or net worth of 969.47 million as of September 4, 2026. Its market cap has decreased by -16.58% in one year.
Market Cap
969.47M
Enterprise Value
1.50B
Revenue
878.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.85
ChartMarket Cap Chart
Since June 27, 2018, Anxo Pharmaceutical's market cap has decreased from 2.16B to 969.47M, a decrease of -55.07%. That is a compound annual growth rate of -9.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 969.47M | -7.46% |
| Dec 31, 2025 | 1.05B | -21.58% |
| Dec 31, 2024 | 1.34B | -50.67% |
| Dec 29, 2023 | 2.71B | 89.95% |
| Dec 30, 2022 | 1.43B | 20.33% |
| Dec 30, 2021 | 1.18B | -13.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.95B |
| InnoPharmax | 1.34B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.14B |
| Prince Pharmaceutical | 1.06B |
| DV Biomed | 999.53M |
| Original BioMedicals | 935.31M |
| Winston Medical Supply | 827.84M |